ArticleFrontiers in cellular and infection microbiology2026
Multi-dimensional epidemiology of pediatric acute respiratory tract infection in Ningbo, China (2020-2024): age-specific susceptibility, pathogen dynamics, and epidemiological trends.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pediatric acute respiratory tract infection (ARTI) constitutes a major global health threat. Since 2020, global containment measures have disrupted pathogen circulation patterns, leading to altered epidemiological profiles across multiple pathogens with marked regional heterogeneity. Current research in Ningbo predominantly focuses on single-pathogen surveillance or short-term monitoring, lacking systematic analysis of multi-pathogen interactive dynamics, age-specific susceptibility mechanisms, and co-infections. Methods: Clinical data from all 191,967 pediatric patients with ARTI at Ningbo LiHuili Hospital (2020-2024) were collected. Laboratory testing including influenza A/B virus (IFV-A/B) detection, Results: From 2020 and 2024, the number of ARTI cases initially increased and then decreased, peaking in 2023. The incidence was highest in autumn and lowest in summer. Among all cases, 75,001 (39.07%) were diagnosed with acute lower respiratory infection (ALRI), with children aged 6 years exhibiting the highest susceptibility. Of the 41,766 cases tested, the overall pathogen detection rate was 67.61%. IFV-A/B, Human Parainfluenza Virus (HPIV), and Human Adenovirus (HAdV) were more frequently detected in acute upper respiratory tract infections (AURI) ( Conclusion: Pediatric ARTI exhibit age-specific susceptibility and pathogen variation. The 2023-2024 resurgence demands precision control strategies for optimized intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.